Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 4 Weeks

25-Mar-17 - 21-Apr-17
Buy Ratio:30%

Up

# Net Buyers:31
# Net Sellers:73

Previous 4 Weeks

25-Feb-17 - 24-Mar-17
Buy Ratio:23%
# Net Buyers:32
# Net Sellers:109
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Mylan N.V.--$1.83B  
Valeant Pharmaceuticals International, Inc.$108.44K$166.54M  
Global Blood Therapeutics, Inc.($1.04M)$51.21M  
Esperion Therapeutics, Inc.--$49.31M  
Allergan Plc$16.46M$34.41M  
New Net Buyers
CompanyNet Buy AmountChange
Valeant Pharmaceuticals International, Inc.$108.44K$166.54M  
Allergan Plc$16.46M$34.41M  
Opko Health, Inc.$1.16M$1.29M  
Cumberland Pharmaceuticals Inc$706.80K$732.75K  
Aerie Pharmaceuticals Inc$83.40K$264.81K  
Largest Negative Net Change
CompanyNet Buy AmountChange
Colucid Pharmaceuticals, Inc.--($716.39M)  
Merck & Co., Inc.($3.42M)($20.54M)  
Vertex Pharmaceuticals Inc / Ma($11.47M)($11.13M)  
la Jolla Pharmaceutical Co--($8.67M)  
Eagle Pharmaceuticals, Inc.($16.43M)($7.49M)  
New Net Sellers
CompanyNet Buy AmountChange
Merck & Co., Inc.($3.42M)($20.54M)  
Juno Therapeutics, Inc.($115.08K)($291.96K)  
Advaxis, Inc.($13.86K)($21.20K)